The Trump administration’s decision to reject a proposal to cover weight-loss drugs under Medicare sparked widespread debate and raised crucial questions about access to potentially life-saving medications for millions of Americans. This controversial move, made in [Insert Date of Decision, if known], ignited a firestorm of criticism from patient advocacy …
Read More »